Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

First regulatory approval for Sjögren’s disease (SjD)

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.